Myriad Genetics (MYGN) Tops Q3 EPS by 4c, Raises Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $6.35 -4.8%
Revenue Growth %: -7.0%
Financial Fact:
Interest income: 300K
Today's EPS Names:
OPY, BNCC, ZVOI, More
Revenue Growth %: -7.0%
Financial Fact:
Interest income: 300K
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q3 EPS of $0.27, $0.04 better than the analyst estimate of $0.23. Revenue for the quarter came in at $196.9 million versus the consensus estimate of $189.1 million.
GUIDANCE:
Myriad Genetics sees Q4 2017 EPS of $0.26-$0.28. Myriad Genetics sees Q4 2017 revenue of $192-194 million.
Myriad Genetics sees FY 2017 EPS of $1.01-$1.03 Myriad Genetics sees FY 2017 revenue of $763-765 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
- Lear Corp. (LEA) Tops Q3 EPS by 39c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
